Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Pietro De Rossi

Dados Biográficos

ID7645336
NOMEPietro De Rossi
PRENOMESPietro
SOBRENOMEDe Rossi
ASSINATURADE ROSSI P
AFILIAÇÕESBambino Gesù Children's Hospital
ORCID0000-0001-5344-7525
VERIFICADOSim
TOTAL DE OBRAS4
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2022
ANO MAIS RECENTE DE PUBLICAÇÃO2025
ÍNDICE H0
  • ADHD in adults and criminal behavior

    Open Access•Martina Nicole Modesti, Silvia Gubbini et al.•ARTICLE•International Journal of Law and…•2025

    INTRODUCTION: ADHD is a neurodevelopmental disorder associated with functional, behavioral, and relational difficulties. Its onset is in childhood, before the age of 12, and it often persists into adulthood. This study investigates the link between ADHD in adulthood, psychiatric comorbidities, and the risk of criminal behavior, analyzing the impact of clinical and sociodemographic variables. METHODS: This cross-sectional study included a sample o…

  • Age-related clinical characteristics of children and adolescents with ADHD

    Open Access•Pietro De Rossi, Barbara D’Aiello et al.•ARTICLE•Frontiers in Psychiatry•2023

    These results should be confirmed in longitudinal observational studies of adequate sample size in order to reliably describe a potential course characterized by worsening of functioning, reduction in ADHD-specific symptoms and increase in general psychopathology during the transition from childhood to adolescence

  • Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD

    Open Access•Barbara D’Aiello, Silvia Di Vara et al.•ARTICLE•International Journal of…•2022

    Methylphenidate (MPH) is the treatment of first choice for developmental ADHD. To date, no reliable method to predict how patients will respond to MPH exists and conflicting results are reported on clinical characteristics of responders. The present study aims to give a more precise characterization of the patients who will respond best to MPH to help clinicians in defining the treatment plan. Age, neuropsychological functioning (i.e., attention …

  • Comparing the Effect of Methylphenidate and Anodal tDCS on Inhibitory Control and Working-Memory in Children and Adolescents with Attention Deficit/Hyperactivity Disorder

    Open Access•Barbara D’Aiello, Andrea Battisti et al.•ARTICLE•International Journal of…•2022

    Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inappropriate levels of attention, hyperactivity, and impulsivity that interfere with individual functioning. The international guidelines recommend targeting ADHD-related neurochemical brain abnormalities by intervening via drug treatment, such as methylphenidate (MPH), as first choice. Drug treatments are usually associated with a huge amount of co…

Sem obras proeminentes nesta página.

  • Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD

    Open Access•Barbara D’Aiello, Silvia Di Vara et al.•ARTICLE•International Journal of…•2022

    Methylphenidate (MPH) is the treatment of first choice for developmental ADHD. To date, no reliable method to predict how patients will respond to MPH exists and conflicting results are reported on clinical characteristics of responders. The present study aims to give a more precise characterization of the patients who will respond best to MPH to help clinicians in defining the treatment plan. Age, neuropsychological functioning (i.e., attention …

  • Comparing the Effect of Methylphenidate and Anodal tDCS on Inhibitory Control and Working-Memory in Children and Adolescents with Attention Deficit/Hyperactivity Disorder

    Open Access•Barbara D’Aiello, Andrea Battisti et al.•ARTICLE•International Journal of…•2022

    Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inappropriate levels of attention, hyperactivity, and impulsivity that interfere with individual functioning. The international guidelines recommend targeting ADHD-related neurochemical brain abnormalities by intervening via drug treatment, such as methylphenidate (MPH), as first choice. Drug treatments are usually associated with a huge amount of co…

  • Age-related clinical characteristics of children and adolescents with ADHD

    Open Access•Pietro De Rossi, Barbara D’Aiello et al.•ARTICLE•Frontiers in Psychiatry•2023

    These results should be confirmed in longitudinal observational studies of adequate sample size in order to reliably describe a potential course characterized by worsening of functioning, reduction in ADHD-specific symptoms and increase in general psychopathology during the transition from childhood to adolescence

  • ADHD in adults and criminal behavior

    Open Access•Martina Nicole Modesti, Silvia Gubbini et al.•ARTICLE•International Journal of Law and…•2025

    INTRODUCTION: ADHD is a neurodevelopmental disorder associated with functional, behavioral, and relational difficulties. Its onset is in childhood, before the age of 12, and it often persists into adulthood. This study investigates the link between ADHD in adulthood, psychiatric comorbidities, and the risk of criminal behavior, analyzing the impact of clinical and sociodemographic variables. METHODS: This cross-sectional study included a sample o…

Attention Deficit Hyperactivity Disorder (4 obras) · Clinical Psychology (4 obras) · Medicine (4 obras) · Psychiatry (4 obras) · Psychology (4 obras) · Clinical Psychology (3 obras) · Methylphenidate (3 obras) · Cognition (2 obras) · Neural and Behavioral Psychology Studies (2 obras) · Working memory (2 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae